Pen peptide is a dosing format, not a name for a single drug or a standardized product. This term can refer to a drug approved for sale that is delivered in a specially designed injection device, a reusable pen designed for specific cartridges, an empty accessory for delivering the substance, or a product sold online whose content, production quality, regulatory status, and intended use remain unclear.
These differences are fundamental when interpreting information regarding peptide peptides.
The device may look familiar, while at the same time not containing a medicinal product that is allowed for sale. The mechanism may properly dose the liquid, but that does not yet mean that the liquid contained in it is suitable for injection. Similarly, a calculator can generate a mathematically correct result without checking whether the information entered into it about the substance, concentration, device markings, or clinical recommendation is correct.
The appearance and way of action of pena therefore only answer part of the questions.
To properly understand what a pen peptide is, one must look at the entire drug-device system: the active substance, the formulation, the concentration, the container, the delivery mechanism, the labeling, the storage requirements, the regulatory status, and the user group for which the product is intended.
These elements are interconnected, but they do not constitute interchangeable types of evidence.
What does the term „pen peptide” mean?
One term, several different types of products
Some peptide medicines are supplied in vials because this format can facilitate administration and provide a controlled delivery mechanism.
A well-known example of drugs that use pen system are insulin preparations.
However, the mere term „pen peptide” does not indicate the active substance, the concentration, the approved indication, the mechanism of action, or the regulatory status.
Products that look similar from the outside may actually constitute completely different drug–device systems.
The disposable pen with a pre-filled cartridge contains a specific formulation placed in the device during production and is intended to operate as a defined product configuration.
The reusable pen, on the other hand, is designed to work with specific replaceable cartridges.
The single-dose device is different from the multi-dose device.
Similarly, the mechanism for providing a constant dose differs from the device that allows selection from among several settings.
Another category consists of an empty pen or similar accessory sold online.
Its availability only shows that you can buy the given device or accessory.
However, it does not prove that the substance subsequently placed inside is approved for sale, sterile, chemically stable, has the correct concentration, conforms to the container, or is suitable for injection.
| Description | What should be determined | What the description itself does not confirm |
|---|---|---|
| Factory-filled pen with medicine | Medicine, power, device and current labeling | Applicability to another formulation |
| Reusable pen | Model of the device and specific system of inserts | Compliance with any inserts |
| Empty pen-type accessory | Designation and validated configuration | Permits for substances placed inside |
| The online „pen peptide” | Content, responsible company and regulatory status | Authenticity or pharmaceutical quality |
| Calculator for pen | Supported products, assumptions, and validation | The correct clinical dose |
This distinction is important because the external appearance of the device itself says relatively little about what is actually inside.
Two products may resemble injection pens while differing in formulation, mechanism, cartridge geometry, dose selection system, intended use, process control, and regulatory status.
Evidence regarding the device and evidence regarding the drug are two different matters
The device’s research and the drug’s studies answer various scientific questions.
In device studies, the accuracy of input, repeatability, the force required to operate, mechanical reliability, ease of use, and the way humans interact with the device can be evaluated.
Clinical studies, on the other hand, verify whether a specific therapeutic product leads to specific results in a defined population.
One type of evidence cannot automatically replace another.
For example, in a 2018 study on a factory-filled insulin pen that allows setting the dose every half unit, technical tests were combined with an evaluation of simulated use involving 60 people. The device tested met the accuracy criteria used in that study.[1]
This is useful evidence regarding the specific configuration of the device that was tested.
It does not confirm the accuracy of another pen.
More importantly, it does not show that a peptide solution placed in a different pen would be suitable, stable, accurately administered, or clinically effective without this device.
A properly functioning delivery mechanism is therefore only one of the components of the medicinal product.
The pen may operate mechanically exactly according to the design, while the identity or quality of its contents remains uncertain.
On the other hand, a correctly identified medicinal product still requires an appropriate and validated administration system if it is to be used with a pen.
The registration number does not automatically mean that a drug is allowed.
Regulatory terminology should be interpreted with caution, as terms such as „registered”, „listed”, „authorized”, „authorized”, or „approved” can have different meanings.
The FDA explains that registration and notification of a facility that manufactures medical devices in itself does not mean approval, admission, or authorization of the devices produced or distributed by that facility.[2]
Therefore, the registration certificate or the plant number should not be presented as proof that a specific pen peptide or its content has been approved.
The same principle applies when claims about the drug and the device are mixed together.
The registration relating to the device does not confirm the pharmaceutical approval of the substance contained within it.
In the case of a medicinal product, the verification should concern the exact name of the product, the active substance, the strength, the pharmaceutical form, the method of presentation, the responsible company and the appropriate jurisdiction.
The regulatory status of one product cannot be automatically transferred to another preparation simply because both contain a substance with a similar name.
The fact that a given active substance is present in a medicinal product that is authorised for sale does not, for example, mean that every product containing that substance is subject to the same approval, quality control, formulation, production standards or labelling.
Regulatory evidence therefore relates to a specific product, and not solely to the name of the ingredient.
The device's compliance with the intended formulation
Physical fit does not mean full compliance
The fact that the physical input fits into the pen does not yet mean that such a connection has been validated.
Mechanical compatibility encompasses much more than the ability to connect two elements.
The cartridges and devices may differ in dimensions, sealing properties, piston movement, internal geometry, force requirements, and the relationship between the displayed setting and the actual volume of the fluid being supplied.
A set that appears compatible may therefore operate differently than the configuration for which the device was originally designed.
Compliance also goes beyond mechanical issues.
The formulation itself must maintain its proper properties when in contact with the cartridge, the closure system, and other essential components throughout the entire period of storage and use.
The product can therefore be mechanically compatible, while leaving unanswered questions regarding the accuracy of dosing, stability, protection against contamination or interaction with materials.
From a scientific point of view, a more useful question is not:
„Does the insert fit?”
but:
„Has the exact combination of formulation, container and device been evaluated for its intended use?”
The mere physical connection of the elements does not provide the answer to this question.
The container is part of the product
The container surrounding the medicinal formulation is not merely a passive packaging.
During formulation development, interactions between the drug and materials that come into contact with it, protection against environmental influences, closure integrity, storage conditions, and the system's performance throughout the entire intended product use period are taken into account.
The FDA draft guidance of August 2026 regarding container closure systems discusses the quality assessment appropriate for a specific product, including systems related to composite products. [3]
Since this is a draft of guidelines, it should not be presented as a final mandatory requirement.
However, its significance for the subject at hand is significant: the formulation and container must be evaluated together.
The stability data of a formulation stored in one validated container therefore do not automatically constitute a basis for transferring the material to another cartridge or pen.
Changing the container can change the scientific question itself.
The new system may introduce other contact materials, space conditions above the product, sealing properties, movement, environmental exposure, or other factors that were not originally studied in the stability test.
Therefore, evidence regarding stability should remain linked to the configuration in which the formulation was actually tested.
We also explain in the article more about why storage conditions must be interpreted in relation to the specific material, formulation and packaging. Storage of peptides: temperature, humidity, and the effects of freezing and thawing.
Accuracy and precision are separate properties
The terms „accuracy” and „precision” are sometimes used interchangeably, although they describe different aspects of measurement performance.
Accuracy determines how close the given quantity is to the intended value.
Precision, on the other hand, describes how similar the subsequent repetitions of a statement are to each other.
The device can therefore give out almost the same amount of power every time, while systematically deviating from the target value.
In that case it would be precise, but consistently inaccurate.
The opposite situation is also possible: the average of several throws may be close to the target value, even though the individual results vary significantly from each other.
The average itself may therefore hide poor repeatability.
A reliable assessment should include more than one summary value.
Researchers can analyze the distribution of results, various device settings, repeated measurements, environmental conditions, acceptance criteria, and other elements of the research protocol.
The general statement that the device is simply „precise” does not describe these details.
It also does not prove that another formulation placed in a device with a similar appearance will behave identically.
Ease of use requires a separate assessment
A device that functions exactly mechanically does not necessarily have to be a device that every intended user will be able to operate correctly.
The human interaction with the device introduces additional questions.
Can the user read the display?
Can he correctly select the correct setting?
Are the feedback generated by the device understandable?
Can the required sequence of actions be performed in a repeatable manner?
Can the user distinguish between the settings, the preparation stages, and the individual states of the device?
These are questions different from whether the internal mechanism works properly during technical tests.
The aforementioned study of insulin pen allowing for settings every half unit included the evaluation of simulated use in addition to technical tests.[1]
This shows why human factor studies can provide information that laboratory tests of the device alone cannot provide.
However, studies of simulated use also have limitations.
Correct performance under controlled test conditions does not mean flawless operation in every real environment and by every user.
The convenient design does not eliminate the need for proper identification of the drug, understandable labeling, and instructions related to the specific product.
The rules for storing and sharing devices depend on the product.
Storage requirements can vary significantly between different pharmaceutical formulations.
There may also be different ones for an unopened product and for a product that is already in use.
Therefore, the general statement that „all peptides must be stored in the refrigerator” cannot replace the official information regarding the storage of a specific medicinal product.
Temperature is only one of the elements of product quality.
Depending on the formulation, exposure to light, storage time, handling of the product, freezing restrictions, the integrity of the device, and other conditions can also be important.
A detailed discussion of this topic can be found in the article Storage of peptides.
The term „multi-donor” also requires proper interpretation.
The multi-dose container is designed for more than one administration.
However, this does not mean that it is intended for use by more than one person.
The labeling of insulin lispro examined for the purposes of this article clearly indicates that a pre-filled pen should not be shared between patients, even after changing the needle.[4]
The same labeling also explains the importance of the dosage window for this particular product.
The overall conclusion is simple:
The number of devices in use and the number of people who can use the device are two separate issues.
Both define instructions related to a specific product.
Concentration, dose and device markings are different concepts
The concentration describes the formulation
The concentration determines the amount of substance present in a specific quantity or volume of the formulation.
It therefore describes the contents of the preparation.
However, it does not specify the amount that a specific person should receive.
This distinction is particularly important in the case of multi-dose products.
A pen can contain enough formulations for several doses.
The total amount contained in the device should therefore not be confused with the amount intended for a single administration.
Similarly, the product name, followed by an unexplained number, provides incomplete information.
The number can mean mass, concentration, volume, activity, total container content, device setting, or another parameter.
It is not safe to assume that the unit is secure.
Scientifically useful description requires the number to be given along with the unit and its interpretation in the context of the identified product.
The dose is a clinical recommendation
A dose means the intended amount used in a specific treatment context.
Its determination depends on the specific drug, indication, patient situation, product information, and other clinically relevant factors.
The pen is the delivery mechanism.
It does not itself determine whether the amount selected by the user is clinically appropriate.
This shows the important limitation of the device's accuracy.
A very precise pen can accurately deliver the incorrect amount resulting from a wrong recommendation.
If the medication has been incorrectly identified, the concentration is different from what was assumed, or the selected amount does not meet the recommended dosage; good technical quality of the device will not correct this fundamental error.
The accuracy of the device and its clinical appropriateness therefore answer two different questions.
One cannot replace the other.
The markings do not have a universal meaning
Different measurement systems describe different properties.
Milligrams describe mass.
Milliliters describe volume.
Biological activity units have significance related to a specific measurement system or product.
The device settings also depend on the specific product.
The audible „click” is merely a mechanical event, until the manufacturer determines its meaning within the validated system.
The click does not have a universal relationship with the mass of the peptide, the volume of the fluid, biological activity, or the recommended amount.
Two pens may make similar sounds or perform similar knob movements without producing equivalent amounts of them.
For example, the insulin lispro labeling reviewed explains that the pen dose window shows the units of insulin and that for this particular product, no dose conversion is required.[4]
This instruction applies to the indicated insulin pen.
It should not be transformed into a general conversion principle for other peptide-based devices.
The general rule is that markings acquire meaning based on a validated product system and its instructions, not on visual similarity to another device.
Mistaking units led to real errors
The confusion between measurement systems is not merely a theoretical problem.
The FDA reported dosing errors associated with semaglutide prepared for injection in situations involving milligrams, milliliters, syringe „units,” and various concentrations.[5]
Some of the reported cases required hospitalization.
These reports concern specific prescription products and specific circumstances of administration.
They should not be presented as proof that every pen for injection is dangerous.
However, they show why the distinction between calculation and interpretation is important.
The calculation may be mathematically correct but clinically or practically incorrect, because an incorrect concentration was introduced, an incorrect unit was assumed, or the device's indication was misinterpreted.
Proper arithmetic therefore cannot correct incorrect product information.
Before any calculation can be useful, the identity of the product, the concentration, the measurement system, and the appropriate instructions must be established.
We discuss more about why concentrations, calculations, and information about reconstitution should not be treated as universal instructions in the article. Dosage and reconstitution of peptides.
What the calculator cannot verify
The online calculator can process numbers according to programmed rules, but it is not able to independently determine whether the entered information actually corresponds to the given medicinal product.
They cannot confirm the molecular identity of the substance contained in the pen. They cannot independently verify that the concentration stated on the label is correct, determine the formulation's compatibility with the device, confirm stability and the absence of impurities, decide whether the intended treatment method is clinically appropriate, or guarantee that its assumptions correspond to the manufacturer's instructions.
These limitations are particularly important because a professionally designed interface can give the impression of being reliable and authoritative.
Professional appearance is not evidence of medical validation.
The calculator can also rely on hidden assumptions regarding concentration levels, device setup jumps, products supported, or the significance of the displayed numbers.
If these assumptions do not correspond to the actual product, the result may look very precise, even though it is based on erroneous input data.
If the product instructions and the calculator are contradictory, the discrepancy must be explained by the person responsible for prescribing or dispensing the medication.
Changing the calculator settings until a number appears likely does not solve the problem of missing product information.
Why information about devices sold online requires verification
The online offer is not proof of the product's authenticity
The mere existence of an online offer shows that something has been put up for sale.
It does not independently confirm that the item exists in the described form, that it will be delivered, or that it is an authentic medicinal product.
In a 2024 study, targeted purchases were made from six illegal online sellers of semaglutide.[6]
Three orders containing vials were delivered, while the three advertised pens were not delivered.
Researchers also identified problems with the materials supplied.
The study included a small, intentionally selected sample.
It therefore does not allow for an assessment of the quality, authenticity, or reliability of all online sellers.
Its meaning is different.
The results show the difference between the online offer and the verified medicinal product.
The photo on the website, the product description, the customer review, or the payment page all show that the seller is presenting a specific offer.
They do not prove that the product delivered in the end will correspond to this declaration.
The documentation must relate to the actual product
The documentation is only useful when it relates to the product being evaluated.
Even an authentic document may be irrelevant to a particular case.
A report regarding another model of the device, formulation, concentration, production batch, or company does not answer the questions regarding the product in front of us.
A useful verification links the supplied product with its current labeling, the responsible company, the batch identifier, the device model, the formulation, and the relevant official registries.
The analysis certificate can provide information about specific tests performed on the sample.
However, its significance remains limited to the scope of these studies.
The analysis certificate does not independently confirm the accuracy of the device.
It does not show its ease of use.
It does not constitute proof of the drug's approval.
It does not specify the appropriate clinical application.
The report should also be able to be linked to the actual sample or batch that is the subject of the assessment.
Technically, a document regarding another batch or product cannot simply be transferred to the subject under assessment.
User reviews do not replace research
Consumer opinions can provide information about the ordering process, packaging, shipping, appearance, or subjective impressions.
However, they are generally unable to confirm the molecular identity, the pharmaceutical concentration, sterility, the presence or absence of impurities, the stability, or the accuracy of the administered amount.
These issues require other types of evidence.
The same restriction applies when published studies are used in product marketing.
The reliable study of a known pen insulin does not constitute transferable validation of another device sold under the broad term „pen peptide”.
The specific tested configuration matters.
The medicine, the cartridge, the mechanism, the formulation, the instructions and the testing conditions are part of the evidence.
Similarity in appearance does not mean equivalence.
Uncertainty should be resolved at the level of the specific product.
General questions such as „Are peptide powders safe?” or „Are peptide powders accurate?” are often too broad to provide a useful answer to, because this term can apply to very different products.
More useful questions identify the system under assessment.
What medicine is in the middle?
What formulation is provided for?
What is the concentration?
What model of device is being used?
What do the markings or displayed values mean?
Which instructions apply specifically to this product?
What regulatory entry corresponds to this drug and device?
These questions transform an ambiguous category into an identifiable product.
This is important because the answer depends on the drug, the device, the formulation, the labeling, and the intended use, not on the shape itself that resembles a pen.
Frequently asked questions
1. Does the pen itself mean that the medicine has been approved?
No. Pen is a dosing format and does not confirm that its contents are approved or authorized for commercial use. Device registration also differs from its approval or authorization, which the FDA explains. [2] A specific medicinal product must be associated with an appropriate official registry in the appropriate jurisdiction. Packaging, appearance, registration number, or similarity to another pen do not substitute for verification of the specific product.
2. Are all peptide pens interchangeable?
No. Coin systems can differ in formulation, input design, dimensions, internal mechanism, input increments, display, labeling, and intended use. A study demonstrating the correct operation of one configuration confirms the properties of that configuration, not all devices with similar shape. Using a different input, formulation, or component creates new questions whose original evidence may not be included. Therefore, compliance must be determined for a specific system.
3. Are the pen and the medicine inside it two different things?
Yes. The delivery mechanism and the therapeutic formulation are separate elements of the entire product. The device must meet appropriate mechanical and user requirements, whereas the drug itself is subject to separate requirements regarding identity, quality, stability, concentration, and clinical evidence. A well-functioning pen does not confirm the quality of an unidentified content, and a proper drug does not automatically validate any delivery device. Both elements must therefore be evaluated together, without mixing their separate functions.
4. Does the fact that the insert fits confirm its compliance with the penis?
No. Physical fit only means that the components can be combined together. It does not confirm the accuracy of the labeling, sealing performance, stability of the formulation, interaction with the container material, or reliability over the entire intended service life. A kit may appear mechanically correct even though it has never been evaluated as a complete system. Therefore, evidence and instructions relating to the specific product are required. Visual and physical similarities do not replace compliance testing.
5. Does a higher concentration mean better quality?
No. Concentration describes the amount of substance in a specific amount or volume of formulation. It does not by itself describe pharmaceutical quality, device accuracy, clinical utility, or efficacy. A more concentrated preparation is not automatically better or more accurately administered. Concentration should be interpreted in conjunction with information about the identified drug, formulation, device, and official instructions, and not be treated as an indicator of quality.
6. Are milligrams and milliliters interchangeable?
No. Milligrams measure mass, while milliliters measure volume. The relationship between them depends on the concentration of the specific formulation. FDA reports of errors in the prescription of semaglutide for injection show that confusion between milligrams, milliliters, syringe „units,” and different concentrations can lead to serious errors. [5] Therefore, numbers should not be interpreted in isolation from their unit and the specific context of the product.
7. Is a single click pen a universal dose unit?
No. A click is a mechanical event generated by a specific device mechanism. There is no universal relationship between the mass of the peptide, the volume of the fluid, biological activity, or the prescribed amount. Similar sounds or movements of the control knob in different devices do not mean equivalent dosing. The meaning of the setting must result from the validated design and the official instructions for the specific product. Therefore, online click count tables should not be transferred from one device to another.
8. Does the pena calculator provide safe use?
No. A calculator can perform mathematical operations without verifying the correctness of the entered information. If the concentration, device model, markings, medication, or assumptions are incorrect, the result obtained can also be misleading, even though it is mathematically consistent. A calculator cannot independently verify the product or determine whether the intended treatment method is clinically appropriate. Its usefulness depends on the previously verified drug-device context and should not replace reliable instructions or professional explanation.
9. Does the mechanical accuracy guarantee proper operation?
No. Mechanical accuracy and the way the user interacts with the device are two separate issues. The Pen can meet technical requirements, but users may still misinterpret the display, select the incorrect setting, or perform the required actions incorrectly. Therefore, device testing may include the evaluation of human factors or simulated use in addition to technical tests. Testing an insulin pen with half-unit increments included both types of information. [1] Even favorable results remain limited to the device, participants, and conditions being tested.
10. Does technical compliance confirm the clinical benefit?
No. Technical or engineering standards assess the specific properties of a device, not the therapeutic efficacy of the administered drug. A mechanism can meet accuracy requirements while containing an unspecified or clinically inappropriate substance. On the other hand, evidence of a drug’s clinical benefit does not automatically mean that every device will administer it reliably. Device validation and clinical evidence therefore address separate questions.
11. Are reusable and disposable pens equivalent?
Not necessarily. They may differ in design, components, handling methods, cartridge systems, intended lifespan, maintenance requirements, and validated configurations. A reusable pen depends on specific replaceable components, whereas a pre-filled disposable product is delivered as a specific combination of drug and device. Evidence regarding one configuration should not automatically be applied to another. The general term „pen” is too broad to confirm equivalence.
12. Can the multi-dose pen be shared after changing the needle?
Pens labeled as intended for a single patient should not be shared. The labeling for insulin lispro examined for the purposes of this article clearly prohibits sharing a factory-filled pen even after changing the needle. [4] The presence of several doses in one container does not mean that the device is intended for multiple people. Changing the external needle also does not indicate that the remaining part of the system remains free of contamination. Therefore, multiple dosing and use by multiple people are separate concepts.
13. Does storing in the refrigerator confirm the product's suitability?
No. Cooling applies only to one of the possible storage conditions. It does not confirm the identity of the contents, pharmaceutical quality, sterility, stability, concentration, compliance with the container, or the integrity of the device. Storage instructions may also differ for unopened and already used products. Some formulations may have additional requirements regarding temperature or handling of the product. Therefore, maintaining an unidentified preparation at low temperature alone cannot validate or confirm its suitability for administration.
14. Does the analysis certificate confirm the entire pen?
No. The analysis certificate presents specific analytical results related to a particular sample or batch. It does not independently confirm the accuracy of the device, the compliance of the insert, ease of use by humans, drug tolerance, clinical efficacy, or appropriate use. The certificate must also correspond to the actual product and batch under evaluation. The laboratory report is valuable within the limits of documented studies, but it should not be treated as a universal certificate approving the entire drug-device system.
15. Can the pen insulin test confirm another peptide device?
No. A pen insulin study may show how the accuracy of administration is assessed, technical parameters or simulated use, but it does not directly confirm the operation of another peptide device. The drug, cartridge, components, mechanism, settings, and test conditions are part of the original evidence. Changing these elements creates a different system that requires its own justification. The common overall pen format does not imply technical or clinical equivalence.
16. Do online reviews confirm the authenticity of the product?
No. Reviews can describe consumer experiences, the delivery process, packaging, or appearance, but they rarely verify the chemical identity, concentration, sterility, quality of production, or regulatory status of the medicinal product. A targeted study of online purchases documented the non-delivery of parts of orders and problems with some delivered products, although a small and deliberately selected sample does not allow to characterize all online sellers. [6] Authenticity requires evidence related to the actual product and its supply chain.
17. What should be explained before interpreting the markings on the pen?
Before interpreting the markings, it should be clearly established: the exact drug, formulation, concentration, device model, clinical recommendation, and current product instructions. Without this information, even seemingly obvious numbers can be given the wrong meaning. Milligrams, milliliters, biological units, display settings, and mechanical clicks are not interchangeable measurement systems. If the information is inconsistent or unclear, the discrepancy should be explained based on information specific to the particular product and with an appropriately qualified physician or pharmacist, rather than using a general online protocol.
Summary
Penicillin peptide should be understood as one of the components of a specific drug-device system, and not as a standardized category of drugs.
Its external shape does not indicate what substance is inside.
The registration number does not automatically mean that the drug is allowed.
The physical fit of the insert does not confirm compliance.
The correct mechanical action does not confirm the pharmaceutical quality.
The markings on the device do not have a universal meaning.
The calculator can perform correct mathematical operations without confirming that its input data corresponds to the actual product.
These differences explain why several different types of evidence may be necessary.
The accuracy of the device refers to how the mechanism delivers the material.
Precision refers to repeatability.
Evidence of usability describes whether the target users are able to operate the device correctly.
The evidence regarding formulations refers to the identity, quality, concentration, stability, and other properties of the medicinal content.
The evidence regarding the container and compliance refers to how the formulation and the dosing system function together.
Regulatory evidence relates to the status of a specific product in a given jurisdiction.
Clinical evidence concerns whether the drug leads to specific results in the appropriate population.
None of these questions should be answered automatically based on evidence relating to another subject.
The same principle applies to online products.
The product offer shows that it has been put up for sale, but it does not prove that the authentic medicinal product will actually be delivered. [6]
The certificate can provide useful analytical information while remaining limited to the studies and samples to which it actually applies.
Opinions may describe user experiences without confirming the molecular identity, sterility, or accuracy of the administration.
The published study of a recognized pen insulin may show how the device is evaluated, but it does not validate another device sold under the broad name of a peptide product.[1]
Concentration, dose, and device markings should also remain separate concepts.
The concentration describes the formulation.
The clinical dose is a recommendation related to the specific context of the treatment.
The device helps to provide the selected amount, but it cannot determine whether it is appropriate.
Therefore, milligrams, milliliters, biological units, display settings, and clicks should never be treated as universally interchangeable.
FDA reports regarding the mislabeling of units for semaglutide injection prepared for injection show the practical importance of this distinction.[5]
The most useful approach is therefore to verify a specific product.
Before drawing broad conclusions, it is necessary to determine the drug, formulation, concentration, container, device model, the significance of the labeling, current product information, the responsible company, the regulatory status, and the intended use.
A pen that looks familiar can be a convenient technological solution.
However, the appearance alone cannot confirm the identity, quality, compliance, regulatory status, or clinical suitability of the product contained within it.
Disclaimer
This article is purely educational and scientifically informative. It discusses the drug-device systems, terminology related to peptide pens, formulation and container issues, device accuracy, regulatory interpretation, measurement terminology, and limitations of information regarding products offered online.
The article does not contain instructions for dosage, dose conversion, number of clicks calculation, filling of devices, transfer of cartridge contents, reconstitution, injection, or modification of the pen or use with a device for which it is not intended.
Examples regarding insulin pens, prescription-only injectable products, online retailers, and regulatory guidelines are provided to clarify issues related to evidence and devices. They should not be interpreted as instructions for the use of another medication or device.
Questions regarding the actual medicinal product, unclear device markings, suspected product defect, uncertain concentration, errors during administration, or discrepancies between the device and the accompanying instructions require evaluation based on accurate product information and consultation with a suitably qualified healthcare professional, a prescribing physician, or the pharmacist issuing the medication.
References
- Kappes, C. M., Kershner, J. R., Morwick, T. M., & Corrigan, S. M. (2018). Assessment of dose accuracy, injection force, and usability of a new half-unit, prefilled insulin pen. Journal of Diabetes Science and Technology, 12(2), 364–372. https://doi.org/10.1177/1932296817736316
- U.S. Food and Drug Administration. (n.d.). Are there “FDA registered” or “FDA certified” medical devices? How do I know what is FDA approved? Retrieved September 29, 2026, from https://www.fda.gov/medical-devices/consumers-medical-devices/are-there-fda-registered-or-fda-certified-medical-devices-how-do-i-know-what-fda-approved
- U.S. Food and Drug Administration. (2026). Container closure systems for human drugs and biological products: Draft guidance for industry. https://www.fda.gov/media/194220/download
- Eli Lilly and Company. (2023). Insulin lispro: Prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=97d5e596-aae1-42c9-ae89-c3780959c467
- U.S. Food and Drug Administration. (2024). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
- Ashraf, A. R., Mackey, T. K., Vida, R. G., Kulcsár, G., Schmidt, J., Balázs, O., Domián, B. M., Li, J., Csákó, I., & Fittler, A. (2024). Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription: Market surveillance, content analysis, and product purchase evaluation study. Journal of Medical Internet Research, 26, e65440. https://doi.org/10.2196/65440